Phase 2 study of DS-8500a

Phase 2 study to evaluate efficacy and safety of DS-8500a in patients with Type 2 Diabetes Mellitus

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222546

Enrollment

Registered

2014-06-30

Start date

2014-06-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

investigational material(s) Generic name etc : DS-8500a INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material :

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Main Inclusion Criteria; Type 2 Diabetes Mellitus

Exclusion criteria

Exclusion criteria: Main Exclusion Criteria; Type 1 Diabetes Mellitus Patients under insulin treatment Patients with hepatic disorder Patients with renal disorder

Design outcomes

Primary

Measure	Time frame
24hr-weighted mean glucose	—

Secondary

Measure	Time frame
Safety, Pharmacokinetics	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026